OMAPATRILAT COMPARED WITH LISINOPRIL IN TREATMENT OF HYPERTENSION AS ASSESSED BY AMBULATORY BLOOD PRESSURE MONITORING: P2.25

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Hypertension

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004872-200006001-00316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Novel Therapies for the Prevention and Management of Acute Decompensated Heart Failure

  2016cites this paper
• Vasopeptidase Inhibition Normalizes Blood Pressure and Restores Endothelial Function in Renovascular Hypertension

  2007cites this paper
• Chapter 31 – Natriuretic Peptides

  2007cites this paper
• A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients

  2006cites this paper
• Current and Future Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents

  2005cites this paper
• Triple Vasopeptidase Inhibition of Angiotensinconverting Enzyme/Neutral Endopeptidase/Endothelinconverting Enzyme Activities on the Hemodynamic Profile of Chronically Instrumented Unrestrained Conscious Spontaneously Hypertensive Rats

  2004influential citation
• Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.

  2004cites this paper
• Renoprotective Effects of Omapatrilat Are Mediated Partially by Bradykinin

  2003cites this paper
• A Review of Vasopeptidase Inhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure

  2002cites this paper
• Renal Hemodynamic and Natriuretic Effects of Concomitant Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibition in Men

  2002cites this paper
• Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.

  2002cites this paper
• Le rôle thérapeutique de l'inhibition de la vasopeptidase dans l'hypertension - Résultats de l'étude OCTAVE

  2002cites this paper
• Novel angiotensin II inhibitors in cardiovascular medicine

  2001cites this paper
• Omapatrilat Versus Lisinopril: Efficacy and Neurohormonal Profile in Salt-Sensitive Hypertensive Patients

  2001cites this paper
• Newer Antihypertensive Agents: Angiotensin-Receptor Antagonists and Vasopeptidase Inhibitors

  2001cites this paper
• Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease?

  2001cites this paper
• Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.

  2001cites this paper
• Effects of Omapatrilat on Blood Pressure and Insulin Sensitivity in an Animal Model of Insulin Resistance

  2001cites this paper